Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
36.21
+3.29 (9.99%)
Apr 30, 2025, 3:04 PM CST
SHE:002422 Revenue
Sichuan Kelun Pharmaceutical had revenue of 4.39B CNY in the quarter ending March 31, 2025, a decrease of -29.42%. This brings the company's revenue in the last twelve months to 19.98B, down -9.31% year-over-year. In the year 2024, Sichuan Kelun Pharmaceutical had annual revenue of 21.81B with 1.67% growth.
Revenue (ttm)
19.98B
Revenue Growth
-9.31%
P/S Ratio
2.88
Revenue / Employee
913.96K
Employees
21,864
Market Cap
57.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21.81B | 358.49M | 1.67% |
Dec 31, 2023 | 21.45B | 2.42B | 12.69% |
Jan 1, 2023 | 19.04B | 1.76B | 10.19% |
Jan 1, 2022 | 17.28B | 813.21M | 4.94% |
Dec 31, 2020 | 16.46B | -1.17B | -6.65% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |